Search Results - "Anderson, Sarah L."

Refine Results
  1. 1

    Quetiapine for insomnia: A review of the literature by ANDERSON, SARAH L, VANDE GRIEND, JOSEPH P

    Published in American journal of health-system pharmacy (01-03-2014)
    “…PURPOSEThe safety and efficacy of quetiapine for the treatment of insomnia in adults are reviewed. SUMMARYQuetiapine was developed for the treatment of…”
    Get full text
    Journal Article
  2. 2

    Tirzepatide for type 2 diabetes by Anderson, Sarah L, Marrs, Joel C

    Published in Drugs in Context (22-08-2023)
    “…One in ten adults worldwide is living with diabetes, with 95% having type 2 diabetes (T2D). Sustained glycaemic control in people with T2D is difficult to…”
    Get full text
    Journal Article
  3. 3

    Suvorexant in insomnia: efficacy, safety and place in therapy by Rhyne, Danielle N., Anderson, Sarah L.

    Published in Therapeutic Advances in Drug Safety (01-10-2015)
    “…Insomnia is a highly prevalent disorder that can occur in conjunction with other medical or psychiatric conditions or can occur in the absence of a coexisting…”
    Get full text
    Book Review Journal Article
  4. 4

    Bempedoic acid for the treatment of dyslipidemia by Marrs, Joel C, Anderson, Sarah L

    Published in Drugs in Context (24-08-2020)
    “…Cardiovascular disease (CVD) is the leading cause of death worldwide and one key factor associated with the increased CVD risk is dyslipidemia. Statin therapy…”
    Get full text
    Journal Article
  5. 5

    Diabetes: how to manage cardiovascular risk in secondary prevention patients by Anderson, Sarah L, Marrs, Joel C

    Published in Drugs in Context (14-06-2022)
    “…Atherosclerotic cardiovascular disease (ASCVD) commonly affects people with type 2 diabetes (T2D). Historically, traditional cardiovascular (CV) risk-lowering…”
    Get full text
    Journal Article
  6. 6

    Ertugliflozin in the treatment of type 2 diabetes mellitus by Marrs, Joel C, Anderson, Sarah L

    Published in Drugs in Context (30-11-2020)
    “…More than 422 million people worldwide have diabetes, with 90–95% having type 2 diabetes (T2D). Glycemic control of T2D has demonstrated reductions in…”
    Get full text
    Journal Article
  7. 7

    Reliability and concurrent validity of the iPhone ® Compass application to measure thoracic rotation range of motion (ROM) in healthy participants by Furness, James, Schram, Ben, Cox, Alistair J, Anderson, Sarah L, Keogh, Justin

    Published in PeerJ (San Francisco, CA) (08-03-2018)
    “…Several water-based sports (swimming, surfing and stand up paddle boarding) require adequate thoracic mobility (specifically rotation) in order to perform the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Do Callous–Unemotional Traits and Conduct Disorder Symptoms Predict the Onset and Development of Adolescent Substance Use? by Anderson, Sarah L., Zheng, Yao, McMahon, Robert J.

    Published in Child psychiatry and human development (01-10-2018)
    “…Despite strong evidence of the relationship between conduct disorder (CD) symptoms and substance use, it is unclear how callous–unemotional (CU) traits predict…”
    Get full text
    Journal Article
  10. 10

    Utility of the SLUMS as a Cognitive Screening Tool Among a Nonveteran Sample of Older Adults by Feliciano, Leilani, Ph.D, Horning, Sheena M., Ph.D, Klebe, Kelli J., Ph.D, Anderson, Sarah L., M.A, Cornwell, R. Elisabeth, Ph.D, Davis, Hasker P., Ph.D

    “…Objectives To investigate the concurrent validity of the Saint Louis University Mental Status examination (SLUMS) by comparing the ability of the Mini-Mental…”
    Get full text
    Journal Article
  11. 11

    Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness by Anderson, Sarah L., Trujillo, Jennifer M.

    Published in Therapeutic Advances in Chronic Disease (01-01-2016)
    “…Type 2 diabetes (T2D) is a highly prevalent disorder that affects millions of people worldwide. The hallmark of T2D is hyperglycemia and, while many treatment…”
    Get full text
    Book Review Journal Article
  12. 12

    Dapagliflozin for the Treatment of Type 2 Diabetes by Anderson, Sarah L, Marrs, Joel C

    Published in The Annals of pharmacotherapy (01-04-2012)
    “…Objective: To review the literature and describe the pharmacologic, pharmacokinetic, and pharmacodynamic properties; clinical safety; and efficacy of…”
    Get full text
    Journal Article
  13. 13

    Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions by Anderson, Sarah L, Bassetti, Matteo, Mangoni, Arduino A

    Published in Drugs in Context (01-01-2021)
    “…The year 2020 was dominated by the COVID-19 pandemic, bringing with it unprecedented advancements in the fields of healthcare and therapeutic interventions as…”
    Get full text
    Journal Article
  14. 14

    Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment by Anderson, Sarah L, Marrs, Joel C

    Published in Drugs in Context (06-08-2018)
    “…Hypertension (HTN) is a common disease state associated with extensive morbidity and mortality worldwide. It is often difficult for patients with HTN to…”
    Get full text
    Journal Article
  15. 15

    Histamine-1 receptor antagonism for treatment of insomnia by Vande Griend, Joseph P., PharmD, BCPS, CGP, Anderson, Sarah L., PharmD, BCPS

    “…Abstract Objectives To evaluate the literature regarding the use of histamine-1 (H1 ) receptor antagonists and to describe their role in the treatment of…”
    Get full text
    Journal Article
  16. 16

    Switching basal insulins in type 2 diabetes: practical recommendations for health care providers by Anderson, Sarah L., Trujillo, Jennifer M., Anderson, John E., Tanenberg, Robert J.

    Published in Postgraduate medicine (17-02-2018)
    “…Basal insulin remains the mainstay of treatment of type 2 diabetes when diet changes and exercise in combination with oral drugs and other injectable agents…”
    Get full text
    Journal Article
  17. 17

    Determining predictors of response to exenatide in type 2 diabetes by Anderson, Sarah L., PharmD, BCPS, Trujillo, Jennifer M., PharmD, BCPS, CDE, McDermott, Michael, MD, Saseen, Joseph J., PharmD, BCPS

    “…Objectives To determine predictors of glycemic response to exenatide and to assess change in glycosylated hemoglobin (A1C) and whether a correlation exists…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Oral semaglutide in type 2 diabetes by Anderson, Sarah L., Beutel, Trevor R., Trujillo, Jennifer M.

    Published in Journal of diabetes and its complications (01-04-2020)
    “…Previously, the only available glucagon-like peptide-1 receptor agonists (GLP-1 RA) were injectable. Approval of oral semaglutide (Rybelsus®) represents the…”
    Get full text
    Journal Article
  20. 20

    Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population by Rhyne, Danielle N., Anderson, Sarah L., Gedde, Margaret, Borgelt, Laura M.

    Published in Pharmacotherapy (01-05-2016)
    “…Study Objective No clinical trials are currently available that demonstrate the effects of marijuana on patients with migraine headache; however, the potential…”
    Get full text
    Journal Article